Journal article
Atherosclerosis Imaging Positron Emission Tomography
PET clinics, v 18(1), pp 71-80
01 Jan 2023
PMID: 36442967
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Assessment of molecular changes by PET has introduced a new paradigm in atherosclerosis imaging, which has traditionally relied on anatomic changes visualized by conventional angiography or computed tomography. The use of 18F-fluorodeoxyglucose (FDG) to identify atherosclerotic changes in the vessel wall was first described more than 2 decades ago. Since then, PET tracers targeting macrophage activity, neoangiogenesis, smooth muscle activity, and other aspects of atherogenic changes have been proposed. The evolving roles of PET tracers including frontrunners FDG and 18F-sodium fluoride, which show arterial wall inflammation and microcalcification, respectively, are discussed
Metrics
Details
- Title
- Atherosclerosis Imaging Positron Emission Tomography
- Creators
- Sze Jia Ng - College Station Medical CenterHui Chong Lau - College Station Medical CenterRizwan Naseer - College Station Medical CenterSimran Sandhu - Pennsylvania State UniversityWilliam Y. Raynor - Hospital of the University of PennsylvaniaThomas J. Werner - Hospital of the University of PennsylvaniaAbass Alavi - Hospital of the University of Pennsylvania
- Publication Details
- PET clinics, v 18(1), pp 71-80
- Publisher
- Elsevier
- Number of pages
- 10
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiology (Radiologic Sciences)
- Web of Science ID
- WOS:000892083800007
- Scopus ID
- 2-s2.0-85142777613
- Other Identifier
- 991020237230004721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Radiology, Nuclear Medicine & Medical Imaging